Submit Deal

ASSERTIO THERAPEUTICS

Summary

Assertio Therapeutics operates as a pharmaceutical company. The Company develops and markets orphan drugs and therapeutic solutions. Assertio Therapeutics serves patients in the United States.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 318 M

Avg. Deal Size£ 159 M

Market Context

Senior Management

Arthur Higgins
President and CEO
Daniel Peisert
CEO
Dan Peisert
CFO

Sort

zyla life sciences

HQ - United States

Pharmaceuticals

20 May 2020

Investment Date

100%

Stake

£ 85 M

Deal Value

spectrum pharmaceuticals

HQ - United States

Biotechnology

31 Jul 2023

Investment Date

100%

Stake

£ 232 M

Deal Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy